The future of the global erectile dysfunction device market looks promising with opportunities in the hospital & ASC and clinic markets. The global erectile dysfunction device market is expected to reach an estimated $2.9 billion by 2030 with a CAGR of 8.3% from 2024 to 2030. The major drivers for this market are increasing prevalence of prostate cancer, growing demand for user friendly ED devices, and rising cases of erectile dysfunctional caused by chronic disease or aging.
Some of the key questions
answered in this exclusive report are:
Q.1. What are some of
the most promising, high-growth opportunities for the erectile dysfunction
device market by age group (less than 40 years, 40-60 years, and more than 60
years), product type (vacuum constriction devices, penile implants, shockwave
therapy, and others), cause (vascular disorders and diabetes, neurological disorders,
and others), end use (hospitals and ASCs and clinics), and region (North
America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will
grow at a faster pace and why?
Q.3. Which region will
grow at a faster pace and why?
Q.4. What are the key
factors affecting market dynamics? What are the key challenges and business
risks in this market?
Q.5. What are the
business risks and competitive threats in this market?
Q.6. What are the
emerging trends in this market and the reasons behind them?
Q.7. What are some of
the changing demands of customers in the market?
Q.8. What are the new
developments in the market? Which companies are leading these developments?
Q.9. Who are the major
players in this market? What strategic initiatives are key players pursuing for
business growth?
Q.10. What are some of
the competing products in this market and how big of a threat do they pose for
loss of market share by material or product substitution?
Q.11. What M&A
activity has occurred in the last 5 years and what has its impact been on the
industry?
Market Segmentation:
In this market, less
than 40 years, 40-60 years, and more than 60 years are the major segments of
erectile dysfunction device market by age group. Lucintel forecasts that more
than 60 years is expected to witness highest growth over the forecast period
due to growing demand for erectile dysfunction devices among patients of this
age range suffering from age-related prostate cancer and CVDs.Within this
market, clinic will remain the largest segment due to growing demand for
erectile dysfunction devices in this setting by healthcare professionals to
treat individuals suffering from prostate cancer or erectile dysfunction
issues.
North America is
expected to witness highest growth over the forecast period due to significant
availibility of high-tech devices and presence of well established healthcare
system in this region.
Boston Scientific,
Rigicon, Coloplast, Promedon, Sanofi, Bayer, and Zephyr Surgical Implants are
the major suppliers in the erectile dysfunction device market.
About
Lucintel
Lucintel, the premier global
management consulting and market research firm, creates winning strategies for
growth. It offers market assessments, competitive analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related reports
1. Pharmaceutical Contract Manufacturing Market
3. Stent Market
4. Wheelchair Market :
5. 3D
Printing Medical Device Market:
8. Medical Lifting Sling
Market:
10. Stretcher Market:
No comments:
Post a Comment